All Resources

Cell Therapy Development

Product Tour: The Opto™ Cell Therapy Development Workflow

Guided by T cell expert, Yelena Bronevetsky, PhD, get a deeper look at how the Opto™ Cell Therapy Development workflow can be used to validate, expand, and fully characterize over a 1,000 T cells.

Cell Therapy Development Lightning System

Brochure: Lightning System

Find out how the Lightning platform lets you visualize diverse cell interactions, measure individual cell cytotoxicity, and recover cells of interest alive.

Antibody Discovery

Webinar: Rapid Discovery of a Diverse Panel of Antibodies Against Membrane Targets Using the Beacon System

Dr. Shireen Khan presents a case study on how ChemPartner has leveraged the Beacon system to rapidly discover cross-reactive antibodies against the GPI-anchored uPA receptor.

Antibody Discovery

Webinar: Rapid Discovery of Functional Antibodies for SARS-CoV-2 Using the Beacon System

Robert Carnahan, PhD, and Seth Zost, PhD, from the Vanderbilt University Medical Center, describe how they have used the Beacon platform, to rapidly discover hundreds of unique antibodies against SARS-CoV-2.

Antibody Discovery

SynBioBeta Live Roundtable: Can Humanity Build a Global Antibody Defense Barrier Against Future Pandemics?

Listen to the world’s leading experts on antibody discovery to discuss how we can build a global defensive barrier to find new therapeutic antibodies against the coronavirus and future pathogens.

Beacon System Lightning System

Datasheet: Cell Analysis Suite (CAS™) 2.1 Software

Review our premier software, its key applications, and the features exclusive to the 2.1 upgrade.

Cell Therapy Development

Webinar: How Pediatric Immune Systems Empower Cancer Immunotherapy

Dr. David Barrett shares insights into why children’s T cells help CAR-T cells succeed and discusses how the Opto Cell Therapy Development Workflow can provide the detailed characterization required to develop more efficacious therapies.

Cell Line Development

Product Tour: The Opto™ CLD Workflow

Antibody expert, Anupam Singhal, PhD, does a 10-minute walkthrough of how the Opto™ CLD workflow makes it possible to produce superior cell lines, with >99% monoclonality assurance, in a matter of days.

Cell Therapy Development

Application Note: Profile and Recover Polyfunctional T Cells Using Multiplexed Cytokine Secretion Assays

Learn how you can easily profile multiple secreted cytokines from live T cells and multiplex with other functional assays.

Antibody Discovery

Datasheet: Opto Plasma B Discovery 2.0 Workflow

Review workflow overview and representative results.

Cell Line Development

Poster: Rapid Generation of Production Cell Lines with Superior Titers and >99% Monoclonality for Complex Antibody Molecules

See how the Opto CLD 2.0 Workflow enables rapid generation of cell lines secreting antibodies for both traditional and non-traditional antibodies while acquiring a superior data package.

Cell Therapy Development

Datasheet: Cytotoxicity Assay

Learn how to track the kinetics of T cell-tumor cell killing behavior in real time.

Cell Therapy Development

Datasheet: Single Cell Cytokine Assays

Review assay overview and results for measuring the release of up to three cytokines from T cells.

Antibody Discovery

Webinar: Antibody Discovery – Select Better Lead Candidates in Under 1 Week

Learn how we enable lead candidate down-selection in 1 day by performing functional characterization during primary screening. Case studies highlight how our customers are dramatically accelerating development of next-generation antibody therapeutics.

Antibody Discovery

Webinar: Accelerating Antibody Discovery in the Modern Therapeutic Landscape

Learn how antibody discovery is changing in today’s therapeutic space. Case studies presented by Abveris highlight accelerated development of next-generation antibody therapeutics.

Antibody Discovery

Application Note: Rapid Selection of Antibodies Against Membrane Targets using Cell-Binding Assays and the Opto™ Plasma B Discovery

Find out how the Opto Plasma B Discovery workflow simplifies and dramatically reduces the time needed to down-select potential lead candidates, even for difficult membrane proteins.

Antibody Discovery

Application Note: Rapidly Discover and Select Potent Ligand/ Receptor Blocking Antibody Lead Candidates with Opto™ Plasma B Discovery

Discover how you can maximize hit recovery and rapidly down-select blocking antibodies from plasma B cells in a single day.

Antibody Discovery

Application Note: Accessing Greater Antibody Sequence Diversity

See how you can discover >5,000 antigen-specific hits from a single plasma B cell sample and recover >650 unique BCR sequences in under 1 week.